drugset / Trial / NCT03940326

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

NCT03940326

Phase 4 Completed 103 enrolled Mazandaran University of Medical Sciences
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is an open-label, active-controlled,non-inferiority trial comparing efficacy and safety of levetiracetam versus valproate in idiopathic generalized tonic-clonic epilepsy.

Timeline

Start
2018-04-01
Primary completion
2019-10-01
Completion
2019-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 2000 mg
Comparator Valproate Small molecule 1500 mg